Reuters logo
BRIEF-Wilson Therapeutics concludes successful talks with FDA and EMA
October 23, 2017 / 6:22 AM / a month ago

BRIEF-Wilson Therapeutics concludes successful talks with FDA and EMA

Oct 23 (Reuters) - WILSON THERAPEUTICS AB:

* ‍DISCUSSIONS WITH U.S FDA AND EMA HAVE BEEN CONCLUDED SUCCESSFULLY​

* DISCUSSIONS ‍REGARDED STUDY PROTOCOL FOR PIVOTAL PHASE 3 FOCUS TRIAL FOR WTX101 IN WILSON DISEASE​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below